green
Positive treatment
8.0 score
Treatment trajectory · 2007 → 2026 · click a year to view as-of
2007
2016
2026
Top citers, strongest first. 4 distinct citers.
How cited ↗
cited
Cited "see"
United States v. Turner
See United States v. Sczubelek, 402 F.3d 175, 182-87 (3d Cir.2005), cert. denied, — U.S.-, 126 S.Ct. 2930 , 165 L.Ed.2d 977 (2006).
discussed
Cited "see"
Wilson v. Wilkinson
See United States v. Sczubelek, 402 F.3d 175 (3d Cir.2005)[, cert. denied, 548 U.S. 919 , 126 S.Ct. 2930 , 165 L.Ed.2d 977 (2006)]; Jones v. Murray, 962 F.2d 302 (4th Cir.1992)[, cert. denied, 506 U.S. 977 , 113 S.Ct. 472 , 121 L.Ed.2d 378 (1992)]; Groceman v. United States Dep’t of Justice, 354 F.3d 411 (5th Cir.2004); United States v. Kincade, 379 F.3d 813 (9th Cir.2004) [ (en banc), cert. denied, 544 U.S. 924 , 125 S.Ct. 1638 , 161 L.Ed.2d 483 (2005)]; Padgett v. Donald, 401 F.3d 1273 (11th Cir.)[, cert. denied sub nom.
discussed
Cited "see"
State v. O'HAGEN
See United States v. Sczubelek, 402 F.3d 175, 183-84 (3d Cir.2005) (applying balancing test in upholding federal DNA statute), cert. denied, — U.S. -, 126 S.Ct. 2930 , 165 L.Ed.2d 977 (2006); Padgett v. Donald, 401 F.3d 1273, 1280 (11th Cir.) (applying balancing test in upholding Georgia’s DNA statute), ce rt. denied sub nom.
Retrieving the full opinion text from the archive…
FEDERAL TRADE COMMISSION
v.
SCHRTINH-PLOUGH CORP. ET AL.
v.
SCHRTINH-PLOUGH CORP. ET AL.
05-273.
Supreme Court of the United States.
Jun 26, 2006.
Cited by 3 opinions | Published
Motions of Henry A. Waxman, National Association of Chain Drug Stores, Public Patent Foundation, Bayer Corporation, and AARP and Prescription Access Litigation Project for leave to file briefs as amici curiae granted. Certiorari denied. JUSTICE BREYER took no part in the consideration or decision of these motions and this petition.